News
New COVID-19 strain has reached the U.S.
September 23, 2021
The CDC has not classified R.1 as a variant of concern yet but noted it has “several mutations of importance” and “demonstrates evidence of increasing virus transmissibility.”
News
Cardiogenic shock teams again tied to lower mortality
September 23, 2021
New data suggest centers with a shock team had higher survival and lower resource use in the cardiac ICU.
![1]()
News
FDA OKs Pfizer COVID booster for 65 and over, those at high risk
September 23, 2021
Emerging evidence shows that booster doses of the Pfizer vaccine cause front-line immune defenders — called binding antibodies — to roughly triple soon after a person gets the third shot.
News
Should hospitalists use albumin to treat non-SBP infections in patients with cirrhosis?
September 22, 2021
Study data suggest that albumin may be beneficial in improving renal and circulatory function.
News
Nurses ‘at the breaking point,’ consider quitting due to COVID issues: Survey
September 21, 2021
“What we’re hearing from our nurses is really shocking.”
![1]()
News
Decline in child COVID may signal end of latest surge
September 21, 2021
United States saw fewer cases and fewer admissions among children, but also fewer vaccinations.
News
Nurses ‘at the breaking point,’ consider quitting due to COVID issues: Survey
September 21, 2021
“Hospitals can have all the beds and all the rooms and all the equipment they want, but without nurses and others at the front lines to provide that essential care, none of it really matters.”
![1]()
News
Refined heart rate cutoffs may improve prognostic value of acute PE scoring systems
September 21, 2021
In an observational registry-based study, dropping the 110-bpm heart rate threshold improved sensitivity for low-risk PE, while increasing it improved specificity for intermediate-high–risk PE.
News
COVID-19 claims more than 675,000 U.S. lives, surpassing the 1918 flu
September 21, 2021
In some ways, the United States has failed to learn from the mistakes of the past.
![1]()
News
EMPEROR-Preserved: Empagliflozin’s HFpEF efficacy catalyzes a heart failure redefinition
September 20, 2021
Cardiologists have long defined heart failure as involving reduced or preserved ejection fraction. Results from big empagliflozin trials say forget that.
